Bridging the Gap Between Participants and Clinical Trials

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

CONDITION

Metabolic and Endocrine

GENDER

Both males and females

AGE GROUP

From 18

and above

STATUS

Recruiting

A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

CONTACT DETAILS

Clinical Trial Site: Paratus Clinical Research Central Coast
Phone Number: 1300742326 Email: info@paratusclinical.com Location: Suite A8, Kanwal Medical Complex, 654 Pacific Highway, KANWAL NSW 2259

Studies Contact Form

Name*
First Last
Email*
Phone Number
Message*
CAPTCHA
- Send me updates about clinical trials
Hidden
All
- All

Approved By: Bellberry Ltd

Clinical Trial Registry Link: Click Here